01. Doctor Overview
Dr. Robert Ramirez is a medical oncologist at the Vanderbilt-Ingram Cancer Center. He previously practiced at the Gayle and Tom Benson Cancer Center at Ochsner Medical Center in New Orleans, Louisiana. He specializes in hematologic and general oncology, as well as thoracic and gastrointestinal cancer. Dr. Ramirez also conducts research in the areas of small cell and non-small cell lung cancers. He worked at both the Ochsner Lung Cancer Multidisciplinary Program and the Ochsner Kenner/LSU Multidisciplinary Neuroendocrine Clinic. Dr. Ramirez is an active member of clinical trial design and education.
Dr. Ramirez received his medical degree from the University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, and completed his residency in internal medicine at Cooper University Hospital in Camden, New Jersey. He serves as a member of the International Association for the Study of Lung Cancer (IASLC), and the North American Neuroendocrine Tumor Society (NANETS).
02. Fast Facts
Doctor Fast Facts
Main Specialty: Oncology
Other Interests & Specialties: Hematologic oncology, general oncology, gastrointestinal cancer, thoracic cancer, non-small cell and small cell cancers and neuroendocrine tumors of the lung.
Certifications, Awards & Accolades: American Board of Internal Medicine Certifications in Internal Medicine and Medical Oncology, Fellow of the American College of Physicians (FACP), member of American Society of Clinical Oncology (ASCO), member of International Association for the Study of Lung Cancer (IASLC), member of the North American Neuroendocrine Tumor Society (NANETS)
Education & Experience:
- Residency for Internal Medicine at Cooper University Hospital
- Fellowship for Hematology/Oncology at the University of Tennessee
- Internship at University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine
- Medical Degree from University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School
Quality of life for non-small cell lung cancer patients in the age of immunotherapy. Translational Lung Cancer Research. April 2018 ;7(Suppl 2):S149-S152. doi: 10.21037/tlcr.2018.03.10
Molecular Targets in Non-Small Cell Lung Cancer. Ochsner Journal. Winter 2017;17(4):388-392.
The Role of Checkpoint Inhibition in Non-Small Cell Lung Cancer. Ochsner Journal. Winter 2017;17(4):379-387.
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer. Annals of Thoracic Surgery. August 2016;102(2):448-53. doi: 10.1016/j.athoracsur.2016.03.096
Lung cancer in HIV-infected patients and the role of targeted therapy. The Journal of Community and Supportive Oncology. August 2015;13(8):282-7. doi: 10.12788/jcso.0152